Cell-mediated Immunity for Prevention of CMV Disease
NCT02538172
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
195
Enrollment
OTHER
Sponsor class
Conditions
Cytomegalovirus Infections
Interventions
OTHER:
T-Track® CMV assay
Sponsor
University of Lausanne Hospitals